LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | PI103 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3794 | 3970 | 0.9555 | 0.9330 |
BT-20 | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4044 | 3970 | 1.0185 | 1.0279 |
BT-20 | QL-X-138 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3182 | 3970 | 0.8013 | 0.7007 |
BT-20 | QL-XII-47 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3397 | 3970 | 0.8555 | 0.7823 |
BT-20 | Radicicol | 0.12 | uM | LJP5 | 72 | hr | 1334 | 1952 | 3970 | 0.4916 | 0.2342 |
BT-20 | Radicicol | 0.12 | uM | LJP6 | 72 | hr | 1334 | 2069 | 3970 | 0.5210 | 0.2786 |
BT-20 | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4007 | 3970 | 1.0092 | 1.0138 |
BT-20 | Ruxolitinib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3911 | 3970 | 0.9850 | 0.9774 |
BT-20 | XL147 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4014 | 3970 | 1.0109 | 1.0165 |
BT-20 | Saracatinib | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3738 | 3970 | 0.9414 | 0.9117 |
BT-20 | Selumetinib | 0.12 | uM | LJP6 | 72 | hr | 1334 | 4277 | 3970 | 1.0772 | 1.1162 |
BT-20 | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 1334 | 2412 | 3970 | 0.6075 | 0.4088 |
BT-20 | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3764 | 3970 | 0.9481 | 0.9218 |
BT-20 | SU11274 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4234 | 3970 | 1.0664 | 1.1001 |
BT-20 | Fedratinib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3935 | 3970 | 0.9910 | 0.9864 |
BT-20 | TGX221 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3991 | 3970 | 1.0051 | 1.0076 |
BT-20 | Torin1 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 1692 | 3970 | 0.4262 | 0.1357 |
BT-20 | Torin2 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 1185 | 3970 | 0.2984 | -0.0568 |
BT-20 | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 1220 | 3970 | 0.3072 | -0.0435 |
BT-20 | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3519 | 3970 | 0.8862 | 0.8286 |
BT-20 | TWS119 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4209 | 3970 | 1.0600 | 1.0903 |
BT-20 | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3808 | 3970 | 0.9591 | 0.9385 |
BT-20 | Withaferin A | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3607 | 3970 | 0.9084 | 0.8620 |
BT-20 | Withaferin A | 0.12 | uM | LJP6 | 72 | hr | 1334 | 4046 | 3970 | 1.0190 | 1.0286 |
BT-20 | WYE-125132 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 2175 | 3970 | 0.5477 | 0.3188 |